1-10 of 10
R Spielberger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Human Papillomavirus (HPV)-Attributable Subsequent Neoplasms (SNs) After Hematopoietic Cell Transplantation (HCT) – a Potentially Preventable Outcome

J Berano Teh, Can-Lan Sun, Ph.D, Sharon Wilczynski, Joel Epstein, R. Spielberger, M.D., Ellie Maghami, Wendy Landier, Ph.D., R.N., Liton Francisco, Saro H. Armenian, DO, MPH, Lennie Wong, PhD, Stephen J. Forman, Smita Bhatia, MD, MPH
Journal: Blood
Blood (2012) 120 (21): 605.
https://doi.org/10.1182/blood.V120.21.605.605
Published: 2012
Journal Articles

Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients

Myo Htut, MD, Ghislaine Gallez-Hawkins, Joycelynne Palmer, PhD, Xueli Liu, R. Spielberger, M.D., Pablo Parker, M.D., Len Farol, MD, Anne Franck, Xiuli Li, Jeannet Laëtitia, Eunicia Reburiano, Valerie Jimenez, Lupe Duarte, CCRC, Chatchada Karanes, MD, Stephen J. Forman, MD, John Zaia, MD, Amrita Krishnan, MD
Journal: Blood
Blood (2011) 118 (21): 5108.
https://doi.org/10.1182/blood.V118.21.5108.5108
Published: 2011
Journal Articles

High Rate of Complete Remission (CR) and Upgraded Response with Weekly Maintenance Bortezomib Post Single Autologous Peripheral Stem Cell Transplant (PSCT) In Patients with Multiple Myeloma. Results of a Phase II Prospective Study

Firoozeh Sahebi, M.D., Amrita Krishnan, M.D., Leonardo Farol, MD, Ji-Lian Cai, MD, George Somlo, MD, Leslie Popplewell, M.D., R. Spielberger, M.D., Neil Martin Kogut, MD, Chatchada Karanes, MD, Christopher Ruel, Paul Frankel, Eunicia Reburiano, Margret O'Donnell, MD, Stephen Forman
Journal: Blood
Blood (2010) 116 (21): 2399.
https://doi.org/10.1182/blood.V116.21.2399.2399
Published: 2010
Journal Articles

Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16).

Margaret O’Donnell, P Parker, A Dagis, ML Slovak, D Snyder, A Stein, R. Spielberger, A Pawlowska, J Rosenthal, J Palmer, N. Kogut, S. J Forman
Journal: Blood
Blood (2008) 112 (11): 3286.
https://doi.org/10.1182/blood.V112.11.3286.3286
Published: 2008
Journal Articles

Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia: A Potential Therapeutic Approach for High Risk ALL Patients Not Eligible for Full Intensity Transplantation

A. Stein, J Palmer, M O’Donnell, N. Kogut, R Spielberger, ML Slovak, NC Tsai, S. J Forman
Journal: Blood
Blood (2008) 112 (11): 4321.
https://doi.org/10.1182/blood.V112.11.4321.4321
Published: 2008
Journal Articles

Final Report on Tandem Autologous Stem Cell Transplantation for Patients with Primary Progressive or Poor Risk Recurrent Hodgkin Lymphoma - A Two Institution Study.

Henry C. Fung, MB, ChB, Patrick Stiff, MD, A. Nademanee, MD, E. Smith, MD, C. Cutrone, MD, M. Parthasarathy, MD, A. Krishnan, MD, J. Klein, MD, A. Molina, MD, C. Ruel, MD, D. Smith, PhD, T. Rodriquez, MD, P. Falk, MD, A. Toor, MD, J. Schriber, MD, J. Rosenthal, MD, B. Ivers, G. Somlo, MD, N. Kogut, MD, N. Vora, MD, K. Margolin, MD, R. Spielberger, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2005) 106 (11): 2071.
https://doi.org/10.1182/blood.V106.11.2071.2071
Published: 2005
Journal Articles

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

Anthony Selwyn Stein, MD, M. O’Donnell, MD, P. Parker, MD, R. Spielberger, MD, A. Nademanee, MD, R. Bhatia, MD, D. S. Snyder, MD, M. Kirschbaum, MD, V. Pullarkat, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, C. Sarkodee-Adoo, MD, M. Slovak, MD, N. Vora, MD, J. Land, RN, A. Dagis, J. Palmer, S. J. Forman, MD
Journal: Blood
Blood (2004) 104 (11): 1870.
https://doi.org/10.1182/blood.V104.11.1870.1870
Published: 2004
Journal Articles

Palifermin Reduces Estimated Downstream Costs of Autologous Stem Cell Transplant (SCT): Analysis of Phase 3 Trial Results.

L.S. Elting, DrPH, Y.C.T. Shih, PhD, P.J. Stiff, MD, W. Bensinger, MD, S.B. Cantor, PhD, C. Cooksley, PhD, R. Spielberger, MD
Journal: Blood
Blood (2004) 104 (11): 2191.
https://doi.org/10.1182/blood.V104.11.2191.2191
Published: 2004
Journal Articles

Peripheral Blood Stem Cells vs Bone Marrow for Matched Sibling Transplant in AML and ALL in First Remission.

Mark Kirschbaum, MD, M. O’Donnell, MD, R. Spielberger, MD, R. Bhatia, MD, V. Pullarkat, MD, A. S. Stein, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, J. Land, RN, C. Sarkodee-Adoo, MD, D. Snyder, MD, S. J. Forman, MD.
Journal: Blood
Blood (2004) 104 (11): 3321.
https://doi.org/10.1182/blood.V104.11.3321.3321
Published: 2004
Journal Articles

Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment [see comments]

P Kampmeier, R Spielberger, J Dickstein, R Mick, H Golomb, JW Vardiman
Journal: Blood
Blood (1994) 83 (10): 2931–2938.
https://doi.org/10.1182/blood.V83.10.2931.2931
Published: 1994